LYPE.DE vs. PPH
LYPE.DE (Amundi MSCI World Health Care UCITS ETF EUR Acc) and PPH (VanEck Vectors Pharmaceutical ETF) are both Health & Biotech Equities funds - LYPE.DE tracks the MSCI World Health Care while PPH tracks the MVIS US Listed Pharmaceutical 25 Index. Both are passively managed. Over the past 10 years, LYPE.DE returned 7.45%/yr vs 7.73%/yr for PPH. A 0.61 correlation means they provide meaningful diversification when combined. LYPE.DE charges 0.30%/yr vs 0.36%/yr for PPH.
Performance
LYPE.DE vs. PPH - Performance Comparison
Loading charts...
Different Trading Currencies
LYPE.DE is traded in EUR, while PPH is traded in USD. To make them comparable, the PPH values have been converted to EUR using the latest available exchange rates.
Returns By Period
In the year-to-date period, LYPE.DE achieves a -2.00% return, which is significantly lower than PPH's 5.37% return. Both investments have delivered pretty close results over the past 10 years, with LYPE.DE having a 7.45% annualized return and PPH not far ahead at 7.73%.
LYPE.DE
- 1D
- 2.79%
- 1M
- 3.48%
- YTD
- -2.00%
- 6M
- -1.61%
- 1Y
- 9.70%
- 3Y*
- 2.46%
- 5Y*
- 5.27%
- 10Y*
- 7.45%
PPH
- 1D
- 1.50%
- 1M
- 5.49%
- YTD
- 5.37%
- 6M
- 8.48%
- 1Y
- 21.51%
- 3Y*
- 10.67%
- 5Y*
- 11.31%
- 10Y*
- 7.73%
LYPE.DE vs. PPH - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
LYPE.DE Amundi MSCI World Health Care UCITS ETF EUR Acc | -2.00% | 2.17% | 7.03% | -0.27% | -0.17% | 30.38% | 2.44% | 27.39% | 5.67% | 5.56% |
PPH VanEck Vectors Pharmaceutical ETF | 5.37% | 7.52% | 15.18% | 3.74% | 9.00% | 26.61% | -3.21% | 22.09% | -1.47% | 1.07% |
Correlation
The correlation between LYPE.DE and PPH is 0.73, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.73 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.62 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.60 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.60 |
Correlation (All Time) Calculated using the full available price history since Sep 30, 2010 | 0.61 |
The correlation between LYPE.DE and PPH shifts across timeframes, from 0.60 (5 years) to 0.73 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LYPE.DE vs. PPH — Risk / Return Rank
LYPE.DE
PPH
LYPE.DE vs. PPH - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amundi MSCI World Health Care UCITS ETF EUR Acc (LYPE.DE) and VanEck Vectors Pharmaceutical ETF (PPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LYPE.DE | PPH | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.58 | ||
| Sortino ratioReturn per unit of downside risk | -0.85 | ||
| Omega ratioGain probability vs. loss probability | 1.13 | 1.23 | -0.10 |
| Calmar ratioReturn relative to maximum drawdown | 0.93 | 2.16 | -1.23 |
| Martin ratioReturn relative to average drawdown | 2.27 | 4.97 | -2.71 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| LYPE.DE | PPH | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.68 | 1.26 | -0.58 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.39 | 0.75 | -0.36 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.51 | 0.44 | +0.06 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.76 | 0.53 | +0.23 |
Drawdowns
LYPE.DE vs. PPH - Drawdown Comparison
The maximum LYPE.DE drawdown since its inception was -25.95%, smaller than the maximum PPH drawdown of -31.54%. Use the drawdown chart below to compare losses from any high point for LYPE.DE and PPH.
Loading charts...
Drawdown Indicators
| LYPE.DE | PPH | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -25.95% | -31.54% | +5.59% |
Max Drawdown (1Y)Largest decline over 1 year | -10.21% | -10.02% | -0.19% |
Max Drawdown (3Y)Largest decline over 3 years | -21.30% | -20.54% | -0.76% |
Max Drawdown (5Y)Largest decline over 5 years | -21.30% | -20.54% | -0.76% |
Max Drawdown (10Y)Largest decline over 10 years | -25.95% | -28.74% | +2.79% |
Current DrawdownCurrent decline from peak | -8.75% | -2.05% | -6.70% |
Average DrawdownAverage peak-to-trough decline | -5.06% | -9.92% | +4.86% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.18% | 4.34% | -0.16% |
Volatility
LYPE.DE vs. PPH - Volatility Comparison
The current volatility for Amundi MSCI World Health Care UCITS ETF EUR Acc (LYPE.DE) is 4.96%, while VanEck Vectors Pharmaceutical ETF (PPH) has a volatility of 6.11%. This indicates that LYPE.DE experiences smaller price fluctuations and is considered to be less risky than PPH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LYPE.DE | PPH | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.96% | 6.11% | -1.15% |
Volatility (6M)Calculated over the trailing 6-month period | 9.76% | 12.03% | -2.27% |
Volatility (1Y)Calculated over the trailing 1-year period | 13.82% | 17.13% | -3.31% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 13.41% | 15.19% | -1.78% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 14.64% | 17.46% | -2.82% |
LYPE.DE vs. PPH - Expense Ratio Comparison
LYPE.DE has a 0.30% expense ratio, which is lower than PPH's 0.36% expense ratio.
Dividends
LYPE.DE vs. PPH - Dividend Comparison
LYPE.DE has not paid dividends to shareholders, while PPH's dividend yield for the trailing twelve months is around 2.04%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LYPE.DE Amundi MSCI World Health Care UCITS ETF EUR Acc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PPH VanEck Vectors Pharmaceutical ETF | 2.04% | 1.78% | 1.98% | 2.09% | 1.55% | 1.62% | 1.66% | 1.77% | 1.97% | 1.92% | 2.43% | 1.93% |
Frequently Asked Questions
LYPE.DE and PPH have a correlation of 0.73, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, LYPE.DE is cheaper at 0.30% per year. The better choice depends on whether you care most about return, fees, risk, or income.
LYPE.DE is cheaper with a 0.30% expense ratio, compared with 0.36% for PPH.
LYPE.DE tracks MSCI World Health Care, while PPH tracks MVIS US Listed Pharmaceutical 25 Index. They also come from different issuers: Amundi and VanEck. Their fees differ too: 0.30% for LYPE.DE and 0.36% for PPH.
Find the right allocation for LYPE.DE and PPH
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer